43 results on '"Koné N"'
Search Results
2. Correction to: You don’t have the guts: a diverse set of fungi survive passage through Macrotermes bellicosus termite guts
- Author
-
Bos, Nick, Guimaraes, Leandro, Palenzuela, Romen, Renelies-Hamilton, Justinn, Maccario, Lorrie, Silue, Simon Kolotchèlèma, Koné, N.’golo Abdoulaye, and Poulsen, Michael
- Published
- 2021
- Full Text
- View/download PDF
3. Une série continue de 27 patients adultes opérés d’un spondylolisthésis isthmique L5-S1 par voie combinée : résultats cliniques et radiologiques à 1 an de suivi
- Author
-
Koné, N., Freitas Olim, E., Coloma, P., Rusconi, A., Chenin, L., Sy, O., Souaré, I.S., and Barrey, C.
- Published
- 2017
- Full Text
- View/download PDF
4. You don’t have the guts: a diverse set of fungi survive passage through Macrotermes bellicosus termite guts
- Author
-
Bos, Nick, Guimaraes, Leandro, Palenzuela, Romen, Renelies-Hamilton, Justinn, Maccario, Lorrie, Silue, Simon Kolotchèlèma, Koné, N.’golo Abdoulaye, and Poulsen, Michael
- Published
- 2020
- Full Text
- View/download PDF
5. Epidemiological Aspects of Lefort II Fractures Treated at Nianankoro Fomba Hospital in Segou: About 17 Cases
- Author
-
Dramé, BM, primary, Diarra, I, additional, Toungara, H, additional, Koné, O, additional, Diallo, M, additional, Koné, N, additional, and Touré, A, additional
- Published
- 2023
- Full Text
- View/download PDF
6. Adams-Oliver Syndrome: About A Case
- Author
-
Sylla, F., primary, Keita, Dr. Lassine, additional, Ba, K., additional, Keita, C., additional, Traore, C., additional, Kanté, M., additional, Koné, N., additional, Fofana, Y., additional, Dicko, A. G., additional, Diakité, M., additional, Kontao, N., additional, Dicko, F., additional, and Sylla, M., additional
- Published
- 2023
- Full Text
- View/download PDF
7. 221 - Prévalences de l’échinococcose, la distomatose et la cysticercose porcine dans un abattoir à Abidjan
- Author
-
Koné, N., primary, Coulibaly, T.J., additional, Senin, C.B.V., additional, Touré, A., additional, Touré, L., additional, Sevidzem, S.L., additional, and Yao-Acapovi, G.L., additional
- Published
- 2022
- Full Text
- View/download PDF
8. Sensibilité de Culex quinquefasciatus aux pyréthrinoïdes en relation avec le niveau d’urbanisation et l’évacuation des eaux usées dans la commune de Yopougon à Abidjan (Côte-d’Ivoire)
- Author
-
Fofana, D., Koné, A. B., Koné, N., Konan, Y. -L., Doannio, J. M. C., and N’goran, K. E.
- Published
- 2012
- Full Text
- View/download PDF
9. Morbidité et mortalité du tétanos dans le service de maladies infectieuses du CHU du Point G à Bamako, Mali (2004–2009)
- Author
-
Minta, D. K., Traoré, A. M., Soucko, A. K., Dembélé, M., Coulibaly, Y., Dicko, M. S., Coulibaly, I., Diany, N., Maboune, N. G. E., Ba-Sall, B., Traoré, A. K., Koné, N., and Traoré, H. A.
- Published
- 2012
- Full Text
- View/download PDF
10. Environmental and biological determinants of Termitomyces species seasonal fructification in central and southern Côte d’Ivoire
- Author
-
Koné, N. A., Dosso, K., Konaté, S., Kouadio, J. Y., and Linsenmair, K. E.
- Published
- 2011
- Full Text
- View/download PDF
11. First Report of Sugarcane Streak Mosaic Virus Infecting Sugarcane in Côte d’Ivoire
- Author
-
Sorho, F., primary, Sérémé, D., additional, Kouamé, D. K., additional, Koné, N., additional, Yao, K. J-E., additional, Ouattara, M. M., additional, Tapsoba, W-P., additional, Ouattara, B., additional, and Koné, D., additional
- Published
- 2021
- Full Text
- View/download PDF
12. Spatio-temporal distribution of tsetse and other biting flies in the Mouhoun River basin, Burkina Faso
- Author
-
KONÉ, N., N’GORAN, E. K., SIDIBE, I., KOMBASSERE, A. W., and BOUYER, J.
- Published
- 2011
- Full Text
- View/download PDF
13. Diagnostic accuracy of swine echinococcosis cytopathological tests and challenges for a differential diagnosis: slaughterhouse data
- Author
-
Toure A., Toure L., Acapovi-Yao G. L., Senin C. B. V., Kone N., Kachani M., and Couacy-Hymann E.
- Subjects
echinococcus spp ,epifluorescence ,histopathology ,pig ,Microbiology ,QR1-502 - Abstract
Echinococcosis disease shows clinical signs similar to many diseases. Hence we report cases that need to be confirmed using appropriate tests. A confirmatory study has been conducted to assess the accuracy of two cytopathological tests, with the histopathology test as the reference standard. The first cytopathological test evaluates the Ziehl Neelsen staining with an epifluorescence microscope (cytopath 1). The second cytopathological test uses the same staining followed by a transmitted light microscope examination (cytopath 2). Of a total of 2524 inspected pigs, 101 suspected cases of echinococcosis were detected, of which 67 were found positive with the two cytopathological tests and the histopathological one. The specificity of cytopath 1 (100 % [95 % CI 100 – 100]) and cytopath 2 (100 % [95 % CI 100;100]) were similar, as well as their respective positive predictive values: 100 % [95 % CI 100 – 100] vs. 100 % [95 % CI 100 – 100]. The sensitivity of cytopath 1 is 79.66 % [95 % CI 69.39 – 89.93], while cytopath 2 equals 66.10 % [95 % CI 54.02 – 78.18]. The difference in sensitivity of both tests was not significant. Negative predictive values found for cytopath 1, and cytopath 2 were 40 [95 % CI 18.53 – 61.47] and 28.57 [95 % CI 11.84 – 45.3], leading to the Generalized Estimating Equations (GEE) Model estimate for an odds ratio of 1.4 [95 % CI 0.41 – 5.2], p = 0.06. Cytopath 1 and cytopath 2 are equivalent in terms of specificity (100 % [95 % CI 100 – 100] vs. 100 % [95 % CI 100;100]) and positive predictive value (100 % [95 % CI 100 – 100]. Cytopath 1 is more sensitive than cytopath 2 but not significant (79.66 % [ 95 % CI 69.39 – 89.93] vs. 66.10 % [95 % CI 54.02 – 78.18]). However, the negative predictive value of cytopath 1 is better than that of cytopath 2: 40 % [95 % CI 18.53 – 61.47] vs. 28.57 % [95 % CI 11.84 – 45.3].
- Published
- 2023
- Full Text
- View/download PDF
14. ACCIDENT VASCULAIRE CEREBRAL (AVC) CHEZ LES PATIENTS DIABETIQUES DE TYPE 2 DANS LE SERVICE DE MEDECINE INTERNE DU CHU DU POINT G.
- Author
-
Traoré, D., Sy, D., Sangaré, M., Keita, K., Konaté, M., Sow, D. S., Nyanke, R. N., Mariko, M., Mariko, M. L., Koné, N., Malle, M., Sangaré, B. B., Dembélé, I. A., Cissoko, M., Soukho, A. K., and Traore, A. K.
- Abstract
Copyright of Mali Médical is the property of Mali Medical, Faculte de Medecine, de Pharmacie et d'Odonto-stomatologie and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
15. Suivi des enfants de moins de 2 ans sous traitement antirétroviral au Centre d’Excellence du CHU Gabriel TOURE (Département de pédiatrie, CHU Gabriel Touré, Bamako, Mali)
- Author
-
Sylla M, Coulibaly Y.A, N’diaye C, Koïta A, Koné N, Bagayoko K, Coulibaly H, Touré S, Dicko F, and Msf Paediatric Days
- Published
- 2017
- Full Text
- View/download PDF
16. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ('Three I's') and HIV-Tuberculosis Service Integration in Lower Income Countries
- Author
-
Charles, M.K., Lindegren, M.L., Wester, C.W., Blevins, M., Sterling, T.R., Dung, N.T., Dusingize, J.C., Avit-Edi, D., Durier, N., Castelnuovo, B., Nakigozi, G., Cortes, C.P., Ballif, M., Fenner, L., Ajayi, S., Anastos, K., Bashi, J., Bishai, W., Boulle, A., Braitstein, P., Carriquiry, G., Carter, J.E., Cegielski, P., Chimbetete, C., Davies, M.-A., Diero, L., Duda, S., Egger, M., Eboua, T.F., Gasser, A., Geng, E., Gnokori, J.C., Hardwicke, L., Hoffmann, C., Huebner, R., Kancheya, N., Kiertiburanakul, S., Kim, P., Lameck, D., Leroy, V., Lewden, C., Mandalakas, A., Maskew, M., McKaig, R., Mofenson, L., Mpoudi-Etame, M., Okwara, B., Phiri, S., Prasitsuebsai, W., Petit, A., Prozesky, H., Reid, S.E., Renner, L., Reubenson, G., Sohn, A., Vo, Q., Walker, D., Wehbe, F., Wejse, C., Williams, C., Wood, R., Wools-Kaloustian, K., Yao, Z., Yunihastuti, E., Zhang, F.J., Zhao, H.X., Han, N., Merati, T.P., Wirawan, D.N., Yuliana, F., Ditangco, R., Uy, E., Bantique, R., Phanuphak, P., Ruxrungtham, K., Avihingsanon, A., Khongphattanayothin, M., Sungkanuparph, S., Sanmeema, N., Chaiwarith, R., Sirisanthana, T., Kotarathititum, W., Pham, T.T., Cuong, D.D., Ha, H.L., Nguyen, V.K., Bui, V.H., Nguyen, T.D., Sohn, A.H., Petersen, B., Cooper, D.A., Law, M.G., Jiamsakul, A., Boettiger, D.C., Wati, D.K., Atmikasari, L.P.P., Malino, I.Y., Nallusamy, R., Chan, K.C., Lumbiganon, P., Kosalaraksa, P., Tharnprisan, P., Udomphanit, T., Phongsamart, W., Wittawatmongkol, O., Dung, K.T.K., Lam, N.V., An, P.N., Loan, N.T., Truong, H.K., Du, T.Q., Chau, N.H., Do, C.V., Ha, M.T., Nipathakosol, P., Kariminia, A., Mutimura, E., Gitembagara, A., Tatwangire, J., Izabelle, I., Niyongabo, T., Twizere, C., Baramperanye, E., Edmonds, A., Yotebieng, M., Azinyue, I., Ayangma, L., Dickinson, D., Eley, B., Fritz, C., Garone, D., Giddy, J., MacPhail, P., Moultrie, H., Ndirangu, J., Pestilli, S., Rabie, H., Stringer, J., Technau, K., Graber, C., Kaeser, F., Keiser, O., Cornell, M., Maxwell, N., Zannou, D.M., Ahouada, C., Akakpo, J., Ahomadegbé, C., Gougounon-Houéto, A., Azon-Kouanou, A., Houngbé, F., Sehonou, J., Koumakpaï, S., Alihonou, F., D'Almeida, M., Hodonou, I., Hounhoui, G., Sagbo, G., Tossa-Bagnan, L., Adjide, H., Drabo, J., Bognounou, R., Dienderé, A., Traore, E., Zoungrana, L., Zerbo, B., Sawadogo, A.B., Zoungrana, J., Héma, A., Soré, I., Bado, G., Tapsoba, A., Yé, D., Kouéta, F., Ouedraogo, S., Ouédraogo, R., Hiembo, W., Gansonré, M., Messou, E., Gnokoro, J.C., Koné, M., Kouakou, G.M., Bosse, C.A., Brou, K., Assi, A.I., Chenal, H., Hawerlander, D., Soppi, F., Minga, A., Abo, Y., Yoboue, J.-M., Eholié, S.P., Amego, M.D.N., Andavi, V., Diallo, Z., Ello, F., Tanon, A.K., Koule, S.O., Anzan, K.C., Guehi, C., Aka, E.A., Issouf, K.L., Kouakou, J.-C., N'Gbeche, M.-S., Pety, T., Kouakou, K., Moh, M., Yao, V.A., Folquet, M.A., Dainguy, M.-E., Kouakou, C., Méa-Assande, V.T., Oka-Berete, G., Zobo, N., Acquah, P., Kokora, M.-B., Timité-Konan, M., Ahoussou, L.D., Assouan, J.K., Sami, M.F., Kouadio, C., Goka, B., Welbeck, J., Sackey, A., Owiafe, S.N., Da Silva, Z.J., Paulo, J., Rodrigues, A., Da Silva, D., Medina, C., Oliviera-Souto, I., Østergaard, L., Laursen, A., Sodemann, M., Aaby, P., Fomsgaard, A., Erikstrup, C., Eugen-Olsen, J., Maïga, M.Y., Diakité, F.F., Kalle, A., Katile, D., Traore, H.A., Minta, D., Cissé, T., Dembelé, M., Doumbia, M., Fomba, M., Kaya, A.S., Traoré, A.M., Traoré, H., Toure, A.A., Dicko, F., Sylla, M., Berthé, A., Traoré, H.C., Koïta, A., Koné, N., N'Diaye, C., Coulibaly, S.T., Traoré, M., Traoré, N., Charurat, M., Alim, G., Dapiap, S., Otu, Igbinoba, F., Benson, O., Adebamowo, C., James, J., Obaseki, Osakede, P., Olasode, J., Seydi, M., Sow, P.S., Diop, B., Manga, N.M., Tine, J.M., Bassabi, C.C., Sy, H.S., Ba, A., Diagne, A., Dior, H., Faye, M., Gueye, R.D., Mbaye, A.D., Patassi, A., Kotosso, A., Kariyare, B.G., Gbadamassi, G., Komi, A., Mensah-Zukong, K.E., Pakpame, P., Lawson-Evi, A.K., Atakouma, Y., Takassi, E., Djeha, A., Ephoévigah, A., Djibril, S.E.-H., Dabis, F., Bissagnene, E., Arrivé, E., Coffie, P., Ekouevi, D., Jaquet, A., Sasco, A.J., Amani, D., Azani, J.-C., Balestre, E., Bessekon, S., Bohossou, F., Gilbert, C., Karcher, S., Gonsan, J.M., Le Carrou, J., Lenaud, S., Nchot, C., Malateste, K., Yao, A.R., Siloué, B., Clouet, G., Dosso, M., Doring, A., Kouakou, A., Rabourdin, E., Rivenc, J., Anglaret, X., Ba, B., Essanin, J.B., Ciaranello, A., Datté, S., Desmonde, S., Diby, J.-S.E., Gottlieb, G.S., Horo, A.G., Kangah, S.N., Malvy, D., Meless, D., Mounkaila-Harouna, A., Ndondoki, C., Shiboski, C., Tchounga, B., Thiébaut, R., Wandeler, G., McGowan, C., Cahn, P., Gotuzzo Herencia, José Eduardo, Reyes, M.W., Grinsztejn, B., Pape, J.W., Padgett, D., and Madero, J.S.
- Subjects
0301 basic medicine ,Program evaluation ,Bacterial Diseases ,poverty ,Physiology ,Antitubercular Agents ,lcsh:Medicine ,HIV Infections ,Pathology and Laboratory Medicine ,Occupational safety and health ,Geographical Locations ,0302 clinical medicine ,case finding ,Health care ,lowest income group ,Medicine and Health Sciences ,Coughing ,Medicine ,Infection control ,030212 general & internal medicine ,lcsh:Science ,fever ,Multidisciplinary ,antiretrovirus agent ,adult ,HIV diagnosis and management ,sputum smear ,Vaccination and Immunization ,3. Good health ,Infectious Diseases ,Caribbean Region ,Tuberculosis Diagnosis and Management ,protective equipment ,tuberculosis control ,Research Article ,medicine.medical_specialty ,isoniazid ,Tuberculosis ,Asia ,integrated health care system ,030106 microbiology ,HIV prevention ,Immunology ,Developing country ,Antiretroviral Therapy ,complication ,610 Medicine & health ,World Health Organization ,Article ,03 medical and health sciences ,Signs and Symptoms ,Tuberculosis diagnosis ,Antiviral Therapy ,Human immunodeficiency virus infection ,night sweat ,360 Social problems & social services ,Environmental health ,parasitic diseases ,Isoniazid ,Humans ,purl.org/pe-repo/ocde/ford#3.01.05 [https] ,human ,coughing ,Poverty ,tuberculin test ,Caribbean ,Preventive medicine ,Infection Control ,AIDS-Related Opportunistic Infections ,business.industry ,screening ,lcsh:R ,Biology and Life Sciences ,occupational safety ,South America ,medicine.disease ,Tropical Diseases ,Diagnostic medicine ,mask ,Public and occupational health ,purl.org/pe-repo/ocde/ford#3.02.07 [https] ,People and Places ,Africa ,Physical therapy ,tuberculostatic agent ,lcsh:Q ,weight reduction ,business ,Physiological Processes - Abstract
SETTING World Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy (IPT), and infection control ("Three I's") for TB prevention and control among persons living with HIV. OBJECTIVE To assess the implementation of the "Three I's" of TB-control at HIV treatment sites in lower income countries. DESIGN Survey conducted between March-July, 2012 at 47 sites in 26 countries: 6 (13%) Asia Pacific, 7 (15%), Caribbean, Central and South America, 5 (10%) Central Africa, 8 (17%) East Africa, 14 (30%) Southern Africa, and 7 (15%) West Africa. RESULTS ICF using symptom-based screening was performed at 38% of sites; 45% of sites used symptom-screening plus additional diagnostics. IPT at enrollment or ART initiation was implemented in only 17% of sites, with 9% of sites providing IPT to tuberculin-skin-test positive patients. Infection control measures varied: 62% of sites separated smear-positive patients, and healthcare workers used masks at 57% of sites. Only 12 (26%) sites integrated HIV-TB services. Integration was not associated with implementation of TB prevention measures except for IPT provision at enrollment (42% integrated vs. 9% non-integrated; p = 0.03). CONCLUSIONS Implementation of TB screening, IPT provision, and infection control measures was low and variable across regional HIV treatment sites, regardless of integration status.
- Published
- 2016
- Full Text
- View/download PDF
17. Production of house fly larvae for animal feed through natural oviposition
- Author
-
Koné, N., primary, Sylla, M., additional, Nacambo, S., additional, and Kenis, M., additional
- Published
- 2017
- Full Text
- View/download PDF
18. Caudal Anesthesia: Experience in the Post-Operative Analgesia in Pediatric Ambulatory Surgery at the University Hospital of Treichville
- Author
-
Ango, P. D., primary, Kohou, K. L., additional, Koné, N., additional, Kouamé, A., additional, Tchimou, A. M. Y., additional, Akremy, A., additional, Bamkolé, S. R., additional, Boua, N., additional, and Brouh, Y., additional
- Published
- 2017
- Full Text
- View/download PDF
19. Tiques et pathogènes transmis par les tiques dans les bovins N’Dama à Madina Diassa, Mali
- Author
-
Tomassone, Laura, Conte, V, Ratto, L, Sartirano, G, Guindo, M, Koné, N, and DE MENEGHI, Daniele
- Subjects
tiques ,faune ixodidienne ,pathogènes ,bovins ,N'Dama ,Mali - Published
- 2011
20. Insects used for animal feed in West Africa
- Author
-
Kenis, M., primary, Koné, N., primary, Chrysostome, C.A.A.M., primary, Devic, E., primary, Koko, G.K.D., primary, Clottey, V.A., primary, Nacambo, S., primary, and Mensah, G.A., primary
- Published
- 2014
- Full Text
- View/download PDF
21. Dating the fungus-growing termites’ mutualism shows a mixture between ancient codiversification and recent symbiont dispersal across divergent hosts
- Author
-
NOBRE, T., primary, KONÉ, N. A., additional, KONATÉ, S., additional, LINSENMAIR, K. E., additional, and AANEN, D. K., additional
- Published
- 2011
- Full Text
- View/download PDF
22. Spatio-temporal distribution of tsetse and other biting flies in the Mouhoun River basin, Burkina Faso
- Author
-
KONÉ, N., primary, N’GORAN, E. K., additional, SIDIBE, I., additional, KOMBASSERE, A. W., additional, and BOUYER, J., additional
- Published
- 2010
- Full Text
- View/download PDF
23. P338 - Suivi des nourrissons nés de mères séropositives à Bamako
- Author
-
Sylla, M., primary, Dicko- Traoré, F., additional, N’Diaye, C., additional, Traoré, Y., additional, Koné, N., additional, and Traoré, N., additional
- Published
- 2010
- Full Text
- View/download PDF
24. Epidémiologie de la maladie de Newcastle en milieu rural au Mali
- Author
-
Sylla, M., primary, Traoré, B., additional, Sidibé, Souleymane, additional, Keita, S. M., additional, Diallo, F. C., additional, Koné, B., additional, Ballo, A., additional, Sangaré, M., additional, and Koné, N. G., additional
- Published
- 2003
- Full Text
- View/download PDF
25. SFP P-099 - Profil et devenir des enfants mis sous ARV avant l’âge de 2 ans
- Author
-
Sylla, M., Coulibaly, Y.A., Diakite, A.A., N’diaye, C., Diallo-Koita, A., and Kone, N.
- Published
- 2014
- Full Text
- View/download PDF
26. Dynamics of tsetse natural infection rates in the Mouhoun river, Burkina Faso, in relation with environmental factors.
- Author
-
Bouyer, J., Koné, N., and Bengaly, Z.
- Subjects
POLYMERASE chain reaction ,ENVIRONMENTAL engineering ,DIPTERA ,MATURATION (Psychology) - Abstract
In Burkina Faso, the cyclical vectors of African animal trypanosomoses (AAT) are riverine tsetse species, namely Glossina palpalis gambiensis Vanderplank (G.p.g.) and Glossina tachinoides Westwood (G. t.) (Diptera: Glossinidae). Experimental work demonstrated that environmental stress can increase the sensitivity of tsetse to trypanosome infection. Seasonal variations of the tsetse infection rates were monitored monthly over 17 months (May 2006-Sept 2007) in two sites (Douroula and Kadomba). In total, 1,423 flies were dissected and the infection of the proboscis, middle intestine and salivary glands was noted. All the positive organs were analyzed using monospecific polymerase chain reaction (PCR) primers. To investigate the role of different environmental factors, fly infection rates were analyzed using generalized linear mixed binomial models using the species, sex, and monthly averages of the maximum, minimum and mean daily temperatures, rainfalls, Land Surface Temperature day (LSTd) and night (LSTn) as fixed effects and the trap position as a random effect. The overall infection rate was 10% from which the predominant species was T. congolense (7.6% of the flies), followed by T. vivax (2.2% of the flies). The best model (lowest AICc) for the global infection rates was the one with the maximum daily temperature only as fixed effect (p<0.001). For T. congolense, the best model was the one with the tsetse species, sex, maximum daily temperature and rainfalls as fixed effect, where the maximum daily temperature was the main effect (p<0.001). The number of T. vivax infections was too low to allow the models to converge. The maturation rate of T. congolense was very high (94%), and G. t. harbored a higher maturation rate (p=0.03). The results are discussed in view of former laboratory studies showing that temperature stress can increase the susceptibility of tsetse to trypanosomes, as well as the possibility to improve AAT risk mapping using satellite images. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
27. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure
- Author
-
Sliewa, K., Norton, G.R., and Kone, N.
- Published
- 2005
- Full Text
- View/download PDF
28. Effects of proactive vs fixed community health care delivery on child health and access to care: a cluster randomised trial secondary endpoint analysis.
- Author
-
Whidden C, Kayentao K, Koné N, Liu J, Traoré MB, Diakité D, Coumaré M, Berthé M, Guindo M, Greenwood B, Chandramohan D, Leyrat C, Treleaven E, and Johnson A
- Subjects
- Humans, Female, Child, Child, Preschool, Community Health Workers, Health Services Accessibility, Mali, Child Health, Community Health Services
- Abstract
Background: Professional community health workers (CHWs) can help achieve universal health coverage, although evidence gaps remain on how to optimise CHW service delivery. We conducted an unblinded, parallel, cluster randomised trial in rural Mali to determine whether proactive CHW delivery reduced mortality and improved access to health care among children under five years, compared to passive delivery. Here we report the secondary access endpoints., Methods: Beginning from 26-28 February 2017, 137 village-clusters were offered care by CHWs embedded in communities who were trained, paid, supervised, and integrated into a reinforced public-sector health system that did not charge user fees. Clusters were randomised (stratified on primary health centre catchment and distance) to care during CHWs during door-to-door home visits (intervention) or based at a fixed village site (control). We measured outcomes at baseline, 12-, 24-, and 36-month time points with surveys administered to all resident women aged 15-49 years. We used logistic regression with cluster-level random effects to estimate intention-to-treat and per-protocol effects over time on prompt (24-hour) treatment within the health sector., Results: Follow-up surveys between February 2018 and April 2020 generated 20 105 child-year observations. Across arms, prompt health sector treatment more than doubled compared to baseline. At 12 months, children in intervention clusters had 22% higher odds of receiving prompt health sector treatment than those in control (cluster-specific adjusted odds ratio (aOR) = 1.22; 95% confidence interval (CI) = 1.06, 1.41, P = 0.005), or 4.7 percentage points higher (adjusted risk difference (aRD) = 0.047; 95% CI = 0.014, 0.080). We found no evidence of an effect at 24 or 36 months., Conclusions: CHW-led health system redesign likely drove the 2-fold increase in rapid child access to care. In this context, proactive home visits further improved early access during the first year but waned afterwards., Registration: ClinicalTrials.gov NCT02694055., Competing Interests: Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding authors) and declare the following activities and relationships: AJ, CW, DD, KK, MBT, NK were employed by Muso at the time of the trial. JL and ET received grants from Muso to contribute to the trial. Muso designed and implemented the trial and the intervention evaluated. Muso received funding to support the trial from USAID Development Innovation Ventures, CRI Foundation, Grand Challenges Canada, and Johnson & Johnson Foundation. MC, MB, and MG were employed by the government of Mali during the trial period. CL is supported by the United Kingdom Medical Research Council (Skills Development Fellowship MR/T032448/1)., (Copyright © 2023 by the Journal of Global Health. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
29. Effectiveness of Four Different Interventions Against Schistosoma haematobium in a Seasonal Transmission Setting of Côte d'Ivoire: A Cluster Randomized Trial.
- Author
-
Ouattara M, Bassa FK, Diakité NR, Hattendorf J, Coulibaly JT, Yao PK, Tian-Bi YT, Konan CK, Assaré RK, Koné N, Guindo-Coulibaly N, Utzinger J, and N'Goran EK
- Subjects
- Animals, Child, Cote d'Ivoire epidemiology, Humans, Praziquantel therapeutic use, Prevalence, Schistosoma haematobium, Seasons, Schistosomiasis drug therapy, Schistosomiasis haematobia drug therapy, Schistosomiasis haematobia epidemiology, Schistosomiasis haematobia prevention & control
- Abstract
Background: Annual mass drug administration (MDA) using praziquantel is the cornerstone of schistosomiasis morbidity control but is not sufficient to interrupt transmission. We implemented a cluster-randomized trial to compare the effectiveness of 4 different intervention packages to interrupt transmission of Schistosoma haematobium in a seasonal transmission setting of Côte d'Ivoire., Methods: Sixty-four localities with a S. haematobium prevalence in school children aged 13-14 years above 4% were randomly assigned to 1 of 4 intervention arms over a 3-year period: (1) the current standard strategy consisting of annual MDA before peak of transmission, (2) annual MDA after peak of transmission, (3) biannual MDA, and (4) standard MDA combined with snail control. The primary outcome was prevalence and intensity of S. haematobium infection in children aged 9-12 years 1 year after the final intervention, using urine filtration performed by experienced microscopists., Results: By study end, we observed the lowest S. haematobium prevalence in the biannual MDA, compared to the standard treatment arm (0.6% vs 7.5%; odds ratio [OR] = 0.07, 95% confidence interval [CI] = .02 to .24). The prevalence in arms 2 and 4 was about 3.5%, which was not statistically significantly different from the standard strategy (both ORs 0.4, 95% CI = .1 to ~1.8). New cases of infection were still observed in all arms at study end., Conclusions: Biannual MDA was the only regimen that outperformed the standard treatment. All strategies resulted in decreased prevalence of infection; however, none of them was able to interrupt transmission of S. haematobium within a 3-year period., Clinical Trials Registration: ISRCTN10926858., (© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.)
- Published
- 2022
- Full Text
- View/download PDF
30. [Strokein type 2 diabetic patients in the internal medicine department of the Teaching Hospital of Point G].
- Author
-
Traoré D, Sy D, Sangaré M, Keita K, Konaté M, Sow DS, Nyanke RN, Mariko M, Mariko ML, Koné N, Malle M, Sangaré BB, Dembélé IA, Cissoko M, Soukho AK, and Traore AK
- Abstract
Introduction: Diabetes is a chronic hyperglycemia which can be discovered with specific organic complications particularly affecting the eyes, kidneys, nerves, heart and vessels. Globally, the prevalence of stroke in people with diabetes is approximately 10%., Objective: Study the epidemiological and clinical aspects of stroke in patients with type 2 diabetes., Methodology: We made a descriptive and analytical study by a retrospective survey over a period of 10 years, in the department of internal medicine at the university Hospital ofPoint G. We focused on all hospitalized patients with type 2 diabetes, in whom the diagnosis of stroke was retained., Results: At the end of the study 24 patients out of 492 diabetes hospitalized in to the period met our inclusion criteria, representing a frequence of 4.9%. The mean age was 64.67 ± 13.409 years with a sex-ratio of 1.4. The reason for hospitalization was muscle weakness in 54.2% of patients. Eighty-seven point five percent (87.5%) of patients were already known to have diabetes before the weakness. Stroke was the mode of discovery of diabetes in 12.5%. Over 70% of our patients had hyperglycemia at the time of admission. Ischemic stroke was seen in 75% of patients., Conclusion: Stroke is a great complication of diabetes witch, can be a way discovery of type 2 diabetes., (Le comité de rédaction se réserve le droit de renvoyer aux auteurs avant toute soumission à l'avis des lecteurs les manuscrits qui ne seraient pas conformes à ces modalités de présentation. En outre il leur conseille de conserver un exemplaire du manuscrit, des figures et des tableaux.)
- Published
- 2022
31. Household factors and under-five mortality in Bankass, Mali: results from a cross-sectional survey.
- Author
-
Boettiger DC, Treleaven E, Kayentao K, Guindo M, Coumaré M, Johnson AD, Whidden C, Koné N, Cissé AB, Padian N, and Liu J
- Subjects
- Female, Humans, Male, Cross-Sectional Studies, Mali epidemiology, Proportional Hazards Models, Infant, Newborn, Infant, Child, Preschool, Infant Mortality, Rural Population, Child Mortality
- Abstract
Background: Rural parts of Mali carry a disproportionate burden of the country's high under-five mortality rate. A range of household factors are associated with poor under-five health in resource-limited settings. However, it is unknown which most influence the under-five mortality rate in rural Mali. We aimed to describe household factors associated with under-five mortality in Bankass, a remote region in central Mali., Methods: We analysed baseline household survey data from a trial being conducted in Bankass. The survey was administered to households between December 2016 and January 2017. Under-five deaths in the five years prior to baseline were documented along with detailed information on household factors and women's birth histories. Factors associated with under-five mortality were analysed using Cox regression., Results: Our study population comprised of 17,408 under-five children from 8322 households. In the five years prior to baseline, the under-five mortality rate was 152.6 per 1000 live births (158.8 and 146.0 per 1000 live births for males and females, respectively). Living a greater distance from a primary health center was associated with a higher probability of under-five mortality for both males (adjusted hazard ratio [aHR] 1.53 for ≥10 km versus < 2 km, 95% confidence interval [CI] 1.25-1.88) and females (aHR 1.59 for ≥10 km versus < 2 km, 95% CI 1.27-1.99). Under-five male mortality was additionally associated with lower household wealth quintile (aHR 1.47 for poorest versus wealthiest, 95%CI 1.21-1.78), lower reading ability among women of reproductive age in the household (aHR 1.73 for cannot read versus can read, 95%CI 1.04-2.86), and living in a household with access to electricity (aHR 1.16 for access versus no access, 95%CI 1.00-1.34)., Conclusions: U5 mortality is very high in Bankass and is associated with living a greater distance from healthcare and several other household factors that may be amenable to intervention or facilitate program targeting.
- Published
- 2021
- Full Text
- View/download PDF
32. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
- Author
-
Ouattara M, Diakité NR, Yao PK, Saric J, Coulibaly JT, Assaré RK, Bassa FK, Koné N, Guindo-Coulibaly N, Hattendorf J, Utzinger J, and N'Goran EK
- Subjects
- Animals, Child, Child, Preschool, Cote d'Ivoire epidemiology, Cross-Sectional Studies, Feces, Female, Humans, Male, Praziquantel therapeutic use, Prevalence, Schistosoma mansoni, Schistosomiasis mansoni epidemiology, Chemoprevention methods, Schistosomiasis epidemiology, Schistosomiasis prevention & control, Schools
- Abstract
Background: Preventive chemotherapy using praziquantel is the mainstay for schistosomiasis control. However, there is little evidence on what is supposed to be the most effective school-based treatment strategy to sustain morbidity control. The aim of this study was to compare differences in Schistosoma mansoni prevalence and infection intensity between three different schedules of school-based preventive chemotherapy in an area with moderate prevalence of S. mansoni in Côte d'Ivoire., Methodology: Seventy-five schools were randomly assigned to one of three intervention arms: (i) annual school-based preventive chemotherapy with praziquantel (40 mg/kg) over four years; (ii) praziquantel treatment only in the first two years, followed by two years whithout treatment; and (iii) praziquantel treatment in years 1 and 3 without treatment in-between. Cross-sectional parasitologic surveys were carried out prior to each round of preventive chemotherapy. The difference in S. mansoni prevalence and infection intensity was assessed by multiple Kato-Katz thick smears, among children aged 9-12 years at the time of each survey. First-grade children, aged 5-8 years who had never received praziquantel, were also tested at baseline and at the end of the study., Principal Findings: Overall, 7,410 children aged 9-12 years were examined at baseline and 7,223 at the final survey. The baseline prevalence of S. mansoni was 17.4%, 20.2%, and 25.2% in arms 1, 2, and 3, respectively. In the final year, we observed the lowest prevalence of 10.4% in arm 1, compared to 18.2% in arm 2 and 17.5% in arm 3. The comparison between arms 1 and 2 estimated an odds ratio (OR) of 0.52 but the difference was not statistically significant (95% confidence interval (CI) = 0.23-1.16). Likewise the difference between arms 1 and 3 lacked statistical significance (OR = 0.55, 95% CI = 0.23-1.29). There was no noteworthy difference observed between arms 2 and 3 (OR = 1.06, 95% CI = 0.64-1.75). The lowest S. mansoni fecal egg counts in the final year survey were observed in arm 1 (7.9 eggs per gram of stool (EPG)). However, compared with 11.5 EPG in arm 2 and 15.4 EPG in arm 3, the difference lacked statistical significance. There were 4,812 first-grade children examined at baseline and 4,513 in the final survey. The overall prevalence of S. mansoni in these children slightly decreased in arms 1 (from 4.5% to 3.6%) and 2 (from 4.7% to 4.3%), but increased in arm 3 (from 6.8% to 7.9%). However, there was no significant difference in prevalence and infection intensity observed between study arms., Conclusions/significance: The three treatment schedules investigated led to a reduction in the prevalence and intensity of S. mansoni infection among children aged 9-12 years. Comparing intervention arms at the end of the study, no statistically significant differences were observed between annual treatement and the other two treatment schedules, neither in reduction of prevalence nor intensity of infection. It is important to combine our results with those of three sister trials conducted simultaneously in other African countries, before final recommendations can be drawn., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
33. Management of COVID-19 infection in patients undergoing hemodialysis.
- Author
-
Boushab BM, Koné N, Baba SEO, Bellattv MJOMEM, Ahmed MMO, Habiboullah HO, Baba EOA, Mohamed OOS, and Basco LK
- Subjects
- Adult, Aged, Female, Hospitalization, Humans, Kidney Failure, Chronic therapy, Length of Stay, Male, Mauritania, Middle Aged, Patient Care methods, Young Adult, COVID-19 therapy, Delivery of Health Care methods, Renal Dialysis methods
- Abstract
Coronavirus disease 2019 (COVID-19), a pandemic affecting the world's population, is particularly threatening to dialysis patients. The purpose of this study was to propose recommendations for prevention and containment of COVID-19 in hemodialysis center situated in a regional hospital in Mauritania. Both COVID-19-infected (n = 11) and -uninfected (n = 16) dialysis patients were hospitalized up to three weeks to improve patient management. All COVID-19-infected patients were cured. Patient care and hygiene in a safe environment are the key factors for a favorable outcome, even in resource-limited settings., Competing Interests: The authors declare no competing interests., (Copyright: Boushab Mohamed Boushab et al.)
- Published
- 2021
- Full Text
- View/download PDF
34. [Stroke in type 2 diabetic patients in the internal medicine department of the Teaching Hospital of Point G].
- Author
-
Traoré D, Sy D, Sangaré M, Keita K, Konaté M, Sow DS, Nyanke RN, Mariko M, Mariko ML, Koné N, Malle M, Sangaré BB, Dembélé IA, Cissoko M, Soukho AK, and Traoré AK
- Abstract
Introduction: Diabetes is a chronic hyperglycemia which can be discovered with specific organic complications particularly affecting the eyes, kidneys, nerves, heart and vessels. Globally, the prevalence of stroke in people with diabetes is approximately 10%., Objective: Study the epidemiological and clinical aspects of stroke in patients with type 2 diabetes., Methodology: We made a descriptive and analytical study by a retrospective survey over a period of 10 years, in the department of internal medicine at the university Hospital ofPoint G. We focused on all hospitalized patients with type 2 diabetes, in whom the diagnosis of stroke was retained., Results: At the end of the study 24 patients out of 492 diabetes hospitalized in to the period met our inclusion criteria, representing a frequence of 4.9%. The mean age was 64.67 ± 13.409 years with a sex-ratio of 1.4. The reason for hospitalization was muscle weakness in 54.2% of patients. Eighty-seven point five percent (87.5%) of patients were already known to have diabetes before the weakness. Stroke was the mode of discovery of diabetes in 12.5%. Over 70% of our patients had hyperglycemia at the time of admission. Ischemic stroke was seen in 75% of patients., Conclusion: Stroke is a great complication of diabetes witch, can be a way discovery of type 2 diabetes., (Le comité de rédaction se réserve le droit de renvoyer aux auteurs avant toute soumission à l'avis des lecteurs les manuscrits qui ne seraient pas conformes à ces modalités de présentation. En outre il leur conseille de conserver un exemplaire du manuscrit, des figures et des tableaux.)
- Published
- 2021
35. First report of Sugarcane Streak Mosaic Virus (SCSMV) infecting sugarcane in Côte d'Ivoire.
- Author
-
Sorho F, Sereme D, Kouamé KD, Koné N, Yao KJE, Ouattara MM, Tapsoba WP, Ouattara B, and Kone D
- Abstract
Sugarcane streak mosaic virus (SCSMV; Poaceavirus; Potiviridae) is the causal agent of streak mosaic disease of sugarcane (Saccharum interspecific hybrids), a major industrial crop that is widely cultivated in tropical and subtropical regions for sugar and ethanol production. was first reported by Hall et al. (1998) from quarantined germplasm material exhibiting mosaic symptoms imported from Pakistan into the USA. Subsequently, the virus was also reported to occur in most of the Asian countries like Bangladesh, India, Indonesia, Iran, Sri Lanka, Thailand, Vietnam and China (Chatenet et al. 2005; Hema et al. 2008, Kasemsin et al. 2016, Putra et al. 2014, Xu et al. 2010, Moradi et al. 2015; Moradi et al. 2018, Zhang et al. 2018). Until now, there is no report of SCSMV outside the Asian continent. From February to October 2018, sugarcane plants exhibiting symptoms such as irregular yellow and green mosaic, interveinal chlorotic specks, and streaks were observed in Bafing (Borotou-Koro), Marahoué (Zuénoula) and Tchologo (Ferkéssédougou) regions of Côte d'Ivoire (Fig. 1a). Varieties under large-scale commercial cultivation such as R570, R579, SP711406, Co997, Co449, M1176/77, M2593/92, M2580/95, and M1400/86 were all symptomatic. A total of 94 sugarcane leaf samples were collected from these regions and, among those, 82 showed disease symptoms and 12 were symptomless. Samples were first tested for the presence of sugarcane mosaic virus (SCMV), which causes mosaic a disease that is already present in Africa. Serological tests with infected sap using a Double Antibody Sandwich (DAS)- Enzyme Linked Immuno Sorbent Assay (ELISA) kit (DSMZ, RT-0166, Braunschweig, Germany) were negative for SCMV and no amplification product was obtained by RT-PCR using primers specific to the coat protein (CP) gene of SCMV (Putra et al. 2003). The 82 symptomatic leaves tested positive by DAS-ELISA with SCSMV antiserum (polyclonal antibodies were graciously provided by Prof. Hema M. of the Sri Venkateswara University, Tirupati, AP, India), whereas the 12 symptomless samples tested negative. To confirm these results, virus free greenhouse-grown sugarcane varieties Co997 and M1176/77, were mechanically inoculated with 10 sap extracts from 10 SCSMV-infected sugarcane leaf samples. Sap was also extracted from DAS-ELISA negative sugarcane leaves and used as negative control. For sap preparation, leaves were homogenized with a mortar in 2 mL of phosphate buffer 0.01 M pH 7.2 (ratio 1:10). Fifteen 4-week-old plants per variety were inoculated separately with each sap. All inoculated plants exhibited streak mosaic symptoms 13 days post-inoculation (fig. 1b), and the presence of SCSMV in the inoculated plants was confirmed by DAS-ELISA. Total RNA was extracted from four symptomatic leaf samples, one symptomless and one DAS-ELISA positive sample using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). cDNA was synthesized using M-MLV Reverse Transcriptase (Promega, Cat.No.M1705, Madison, WI, USA) following the manufacturer's instructions. A 690-nucleotide fragment of the CP gene was amplified by reverse transcription-polymerase chain reaction (RT-PCR) with primers SCSMV-F690 and SCSMV-R690 (Viswanathan et al. 2008). All primers were synthesized by Eurogentec (Seraing, Belgium). Aliquots of RT-PCR products (5 μl) were analyzed by electrophoresis on 1.2 % (w/v) agarose gel, stained with ethidium bromide and visualized on a UV transilluminator (Fig. 2). An amplification product of the expected size was obtained for all five symptomatic or DAS ELISA positive but not for the symptomless sample. Two RT-PCR products were sequenced and deposited in GenBank under accession Nos. LR594547 and LR594582. These partial CP gene sequences shared highest nucleotide identity with two isolates of SCSMV from India in GenBank: 91% with JN315855 and 90% with EF655859, thus confirming that SCSMV was occurring in sugarcane in Côte d'Ivoire. To our knowledge, this is the first report of natural infection of sugarcane by SCSMV in Africa. Streak mosaic is a serious threat to the entire sugar industry in West Africa and needs further investigations as it may affect sugarcane yields and impact local economies. Our findings further illustrate the need to develop virus-free germplasm for local, national, and international distribution of sugarcane.
- Published
- 2020
- Full Text
- View/download PDF
36. About an observation of coccydynia treated by surgery.
- Author
-
Koné N
- Published
- 2020
- Full Text
- View/download PDF
37. Epidemiology of intestinal parasite infections in three departments of south-central Côte d'Ivoire before the implementation of a cluster-randomised trial.
- Author
-
Coulibaly G, Ouattara M, Dongo K, Hürlimann E, Bassa FK, Koné N, Essé C, Yapi RB, Bonfoh B, Utzinger J, Raso G, and N'Goran EK
- Abstract
Hundreds of millions of people are infected with helminths and intestinal protozoa, particularly children in low- and middle-income countries. Preventive chemotherapy is the main strategy to control helminthiases. However, rapid re-infection occurs in settings where there is a lack of clean water, sanitation and hygiene. In August and September 2014, we conducted a cross-sectional epidemiological survey in 56 communities of three departments of south-central Côte d'Ivoire. Study participants were invited to provide stool and urine samples. Stool samples were examined for helminth and intestinal protozoa infections using the Kato-Katz technique and a formalin-ether concentration method. Urine samples were subjected to a filtration method for the diagnosis of Schistosoma haematobium . Information on sociodemographic characteristics, knowledge, attitude, practices and beliefs with regard to hygiene, sanitation and intestinal parasitic diseases were collected using a questionnaire administered to household heads. Multivariable logistic regression models were employed to analyse associations between parasite infections and risk factors. Overall, 4,305 participants had complete parasitological and questionnaire data. Hookworm was the predominant helminth species (21.2%), while Ascaris lumbricoides , Trichuris trichiura , Schistosoma mansoni and S. haematobium showed prevalences below 10%. Infections with pathogenic intestinal protozoa (e.g. Entamoeba histolytica / E . dispar and Giardia intestinalis ) were similarly prevalent in the three departments. Hookworm infection was associated with open defecation and participants' age and sex. Entamoeba coli infection was negatively associated with the use of tap water at home (odds ratio (OR) = 0.66; p = 0.032). Disposal of garbage in close proximity to people's home was positively associated with G . intestinalis (OR = 1.30; p = 0.015). Taken together, helminth and intestinal protozoa infections affected a considerable proportion of rural dwellers in south-central Côte d'Ivoire at the onset of a cluster-randomised intervention trial. Our results will serve as baseline to monitor the effect of a package of interventions, including preventive chemotherapy, sanitation and health education on re-infection with helminths and intestinal protozoa., Trial Registration: ISRCTN53102033 (date assigned: 26 March 2014).
- Published
- 2018
- Full Text
- View/download PDF
38. A case of tuberous sclerosis complex revealed by epilepsy.
- Author
-
Koné N and Elhousseine MO
- Published
- 2017
- Full Text
- View/download PDF
39. About an observation of cerebral abscess encysted.
- Author
-
Koné N and Soumaré S
- Published
- 2017
- Full Text
- View/download PDF
40. [Bilateral three-level lumbar spondylolysis].
- Author
-
Koné N and Soumaré O
- Published
- 2017
- Full Text
- View/download PDF
41. Reasons for hospitalization in HIV-infected children in West Africa.
- Author
-
Dicko F, Desmonde S, Koumakpai S, Dior-Mbodj H, Kouéta F, Baeta N, Koné N, Akakpo J, Signate Sy H, Ye D, Renner L, Lewden C, and Leroy V
- Subjects
- AIDS-Related Opportunistic Infections epidemiology, Africa, Western epidemiology, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Length of Stay statistics & numerical data, Male, Prospective Studies, HIV Infections complications, Hospitalization statistics & numerical data
- Abstract
Introduction: Current knowledge on morbidity and mortality in HIV-infected children comes from data collected in specific research programmes, which may offer a different standard of care compared to routine care. We described hospitalization data within a large observational cohort of HIV-infected children in West Africa (IeDEA West Africa collaboration)., Methods: We performed a six-month prospective multicentre survey from April to October 2010 in five HIV-specialized paediatric hospital wards in Ouagadougou, Accra, Cotonou, Dakar and Bamako. Baseline and follow-up data during hospitalization were recorded using a standardized clinical form, and extracted from hospitalization files and local databases. Event validation committees reviewed diagnoses within each centre. HIV-related events were defined according to the WHO definitions., Results: From April to October 2010, 155 HIV-infected children were hospitalized; median age was 3 years [1-8]. Among them, 90 (58%) were confirmed for HIV infection during their stay; 138 (89%) were already receiving cotrimoxazole prophylaxis and 64 children (40%) had initiated antiretroviral therapy (ART). The median length of stay was 13 days (IQR: 7-23); 25 children (16%) died during hospitalization and four (3%) were transferred out. The leading causes of hospitalization were WHO stage 3 opportunistic infections (37%), non-AIDS-defining events (28%), cachexia and other WHO stage 4 events (25%)., Conclusions: Overall, most causes of hospitalizations were HIV related but one hospitalization in three was caused by a non-AIDS-defining event, mostly in children on ART. HIV-related fatality is also high despite the scaling-up of access to ART in resource-limited settings.
- Published
- 2014
- Full Text
- View/download PDF
42. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.
- Author
-
Ekouevi DK, Balestre E, Coffie PA, Minta D, Messou E, Sawadogo A, Minga A, Sow PS, Bissagnene E, Eholie SP, Gottlieb GS, Dabis F, Zannou DM, Ahouada C, Akakpo J, Ahomadegbé C, Bashi J, Gougounon-Houéto A, Azon-Kouanou A, Houngbé F, Koumakpaï S, Alihonou F, d'Almeida M, Hodonou I, Hounhoui G, Sagbo G, Tossa-Bagnan L, Adjide H, Drabo J, Bognounou R, Dienderé A, Traore E, Zoungrana L, Zerbo B, Sawadogo AB, Zoungrana J, Héma A, Soré I, Bado G, Tapsoba A, Yé D, Kouéta F, Ouedraogo S, Ouédraogo R, Hiembo W, Gansonré M, Messou E, Gnokoro JC, Koné M, Kouakou GM, Bosse CA, Brou K, Assi AI, Chenal H, Hawerlander D, Soppi F, Minga A, Abo Y, Bomisso G, Eholié SP, Amego MD, Andavi V, Diallo Z, Ello F, Tanon AK, Koule SO, Anzan KC, Guehi C, Aka EA, Issouf KL, Kouakou JC, N'gbeche MS, Touré P, Avit-Edi D, Kouakou K, Moh M, Yao VA, Folquet MA, Dainguy ME, Kouakou C, Méa-Assande VT, Oka-Berete G, Zobo N, Acquah P, Kokora MB, Eboua TF, Timité-Konan M, Ahoussou LD, Assouan JK, Sami MF, Kouadio C, Renner L, Goka B, Welbeck J, Sackey A, Owiafe SN, Wejse C, Silva ZJ, Paulo J, Rodrigues A, da Silva D, Medina C, Oliviera-Souto I, Ostergaard L, Laursen A, Sodemann M, Aaby P, Fomsgaard A, Erikstrup C, Eugen-Olsen J, Maïga MY, Diakité FF, Kalle A, Katile D, Traore HA, Minta D, Cissé T, Dembelé M, Doumbia M, Fomba M, Kaya AS, Traoré AM, Traoré H, Toure AA, Dicko F, Sylla M, Berthé A, Traoré HC, Koïta A, Koné N, N'diaye C, Coulibaly ST, Traoré M, Traoré N, Charurat M, Ajayi S, Dapiap S, Otu, Igbinoba F, Benson O, Adebamowo C, James J, Obaseki, Osakede P, Olasode J, Sow PS, Diop B, Manga NM, Tine JM, Signate Sy H, Ba A, Diagne A, Dior H, Faye M, Gueye RD, Mbaye AD, Patassi A, Kotosso A, Kariyare BG, Gbadamassi G, Komi A, Mensah-Zukong KE, Pakpame P, Lawson-Evi AK, Atakouma Y, Takassi E, Djeha A, Ephoévi-Gah A, Djibril Sel-H, Dabis F, Bissagnene E, Arrivé E, Coffie P, Ekouevi D, Jaquet A, Leroy V, Lewden C, Sasco A, Azani JC, Allou G, Balestre E, Bohossou F, Karcher S, Gonsan JM, Carrou JL, Lenaud S, Nchot C, Malateste K, Yao AR, Siloué B, Clouet G, Djetouan H, Doring A, Kouakou A, Rabourdin E, Rivenc J, Anglaret X, Ba B, Essanin JB, Ciaranello A, Datté S, Desmonde S, Diby JS, Gottlieb GS, Horo AG, Kangah SN, Malvy D, Meless D, Mounkaila-Harouna A, Ndondoki C, Shiboski C, Thiébaut R, Pac-Ci, and Abidjan
- Subjects
- Adult, Africa, Western epidemiology, Cohort Studies, Female, HIV Infections virology, Humans, Male, Middle Aged, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, HIV-1 isolation & purification, HIV-2 isolation & purification
- Abstract
Background: HIV-2 is endemic in West Africa. There is a lack of evidence-based guidelines on the diagnosis, management and antiretroviral therapy (ART) for HIV-2 or HIV-1/HIV-2 dual infections. Because of these issues, we designed a West African collaborative cohort for HIV-2 infection within the framework of the International epidemiological Databases to Evaluate AIDS (IeDEA)., Methods: We collected data on all HIV-2 and HIV-1/HIV-2 dually seropositive patients (both ARV-naive and starting ART) and followed-up in clinical centres in the IeDEA-WA network including a total of 13 clinics in five countries: Benin, Burkina-Faso Côte d'Ivoire, Mali, and Senegal, in the West Africa region., Results: Data was merged for 1,754 patients (56% female), including 1,021 HIV-2 infected patients (551 on ART) and 733 dually seropositive for both HIV-1 and HIV 2 (463 on ART). At ART initiation, the median age of HIV-2 patients was 45.3 years, IQR: (38.3-51.7) and 42.4 years, IQR (37.0-47.3) for dually seropositive patients (p = 0.048). Overall, 16.7% of HIV-2 patients on ART had an advanced clinical stage (WHO IV or CDC-C). The median CD4 count at the ART initiation is 166 cells/mm(3), IQR (83-247) among HIV-2 infected patients and 146 cells/mm(3), IQR (55-249) among dually seropositive patients. Overall, in ART-treated patients, the CD4 count increased 126 cells/mm(3) after 24 months on ART for HIV-2 patients and 169 cells/mm(3) for dually seropositive patients. Of 551 HIV-2 patients on ART, 5.8% died and 10.2% were lost to follow-up during the median time on ART of 2.4 years, IQR (0.7-4.3)., Conclusions: This large multi-country study of HIV-2 and HIV-1/HIV-2 dual infection in West Africa suggests that routine clinical care is less than optimal and that management and treatment of HIV-2 could be further informed by ongoing studies and randomized clinical trials in this population.
- Published
- 2013
- Full Text
- View/download PDF
43. Contrasting population structures of two vectors of African trypanosomoses in Burkina Faso: consequences for control.
- Author
-
Koné N, Bouyer J, Ravel S, Vreysen MJ, Domagni KT, Causse S, Solano P, and de Meeûs T
- Subjects
- Animals, Burkina Faso epidemiology, Female, Insect Control methods, Male, Microsatellite Repeats, Trypanosomiasis, African prevention & control, Trypanosomiasis, African transmission, Tsetse Flies genetics, Disease Vectors, Trypanosomiasis, African veterinary, Tsetse Flies classification, Tsetse Flies growth & development
- Abstract
Background: African animal trypanosomosis is a major obstacle to the development of more efficient and sustainable livestock production systems in West Africa. Riverine tsetse species such as Glossina palpalis gambiensis Vanderplank and Glossina tachinoides Westwood are the major vectors. A wide variety of control tactics is available to manage these vectors, but their removal will in most cases only be sustainable if the control effort is targeting an entire tsetse population within a circumscribed area., Methodology/principal Findings: In the present study, genetic variation at microsatellite DNA loci was used to examine the population structure of G. p. gambiensis and G. tachinoides inhabiting four adjacent river basins in Burkina Faso, i.e. the Mouhoun, the Comoé, the Niger and the Sissili River Basins. Isolation by distance was significant for both species across river basins, and dispersal of G. tachinoides was ∼3 times higher than that of G. p. gambiensis. Thus, the data presented indicate that no strong barriers to gene flow exists between riverine tsetse populations in adjacent river basins, especially so for G. tachinoides., Conclusions/significance: Therefore, potential re-invasion of flies from adjacent river basins will have to be prevented by establishing buffer zones between the Mouhoun and the other river basin(s), in the framework of the PATTEC (Pan African Tsetse and Trypanosomosis Eradication Campaign) eradication project that is presently targeting the northern part of the Mouhoun River Basin. We argue that these genetic analyses should always be part of the baseline data collection before any tsetse control project is initiated.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.